These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 3158842

  • 21. [Effects of buflomedil on peripheral arteriopathies. An open clinical study].
    Longo FN, Potortì F, Urbano O, Perroni GB.
    Minerva Cardioangiol; 1988 May; 36(5):249-52. PubMed ID: 3059229
    [No Abstract] [Full Text] [Related]

  • 22. [Therapy of chronic arterial occlusive disease. Studies with an orally administered drug under ambulatory conditions].
    Wampola H.
    Fortschr Med; 1977 May 12; 95(18):1240,1242-5. PubMed ID: 405291
    [Abstract] [Full Text] [Related]

  • 23. [Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial].
    Rossini A, Tascino C, Costa F.
    Minerva Cardioangiol; 1998 Nov 12; 46(11):457-69. PubMed ID: 10207294
    [Abstract] [Full Text] [Related]

  • 24. Double-blind placebo-controlled trial of buflomedil in intermittent claudication.
    Fonseca V, Mikhailidis DP, Barradas MA, Jeremy JY, Gracey L, Dandona P.
    Int J Clin Pharmacol Res; 1988 Nov 12; 8(5):377-81. PubMed ID: 3229875
    [Abstract] [Full Text] [Related]

  • 25. [Buflomedil chlorhydrate in peripheral vasculopathies].
    Dall'Antonia F, Perbellini A, Adami CA, Dal Cortivo G, Bucci S.
    Clin Ter; 1986 Dec 15; 119(5):379-85. PubMed ID: 2951055
    [No Abstract] [Full Text] [Related]

  • 26. [Treatment possibilities of arterial circulatory disorders using calcitonin].
    Staehelin A.
    Schweiz Med Wochenschr; 1977 Dec 10; 107(49):1865-7. PubMed ID: 337477
    [Abstract] [Full Text] [Related]

  • 27. Pharmacological preconditioning of ischaemia.
    Laghi Pasini F, Capecchi PL, Acciavatti A, Petri S, de Lalla A, Cati G, Colafati M, Di Perri T.
    Clin Hemorheol Microcirc; 1997 Dec 10; 17(1):73-84. PubMed ID: 9181761
    [Abstract] [Full Text] [Related]

  • 28. Buflomedil in peripheral arterial disease: trials and tribulations.
    Conte MS.
    Circulation; 2008 Feb 12; 117(6):717-9. PubMed ID: 18268159
    [No Abstract] [Full Text] [Related]

  • 29. [Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy].
    Heidrich H.
    Dtsch Med Wochenschr; 1985 Aug 02; 110(31-32):1219-24. PubMed ID: 3926447
    [No Abstract] [Full Text] [Related]

  • 30. Effects of buflomedil hydrochloride in occlusive arterial disease of the lower limbs stage IV.
    Briguglio F, Briguglio E, Di Marco V, Swat M, Materia G, Intilisano A.
    J Int Med Res; 1986 Aug 02; 14(3):115-23. PubMed ID: 3721052
    [Abstract] [Full Text] [Related]

  • 31. [Survey on adherence to hygiene and dietary rules in patients with arterial occlusive disease].
    Aligne C, Mosnier M, Mistretta F, Larguier JS.
    J Mal Vasc; 2000 Jun 02; 25(3):187-94. PubMed ID: 10906634
    [Abstract] [Full Text] [Related]

  • 32. [Training by walking and drug therapy of peripheral arterial occlusive disease].
    Kiesewetter H, Blume J, Jung F, Gerhards M, Leipnitz G.
    Vasa Suppl; 1987 Jun 02; 20():384-7. PubMed ID: 3321495
    [No Abstract] [Full Text] [Related]

  • 33. Peripheral arterial disease: drug therapy.
    Schwartz JB.
    J Gend Specif Med; 2002 Jun 02; 5(4):16-20. PubMed ID: 12192882
    [No Abstract] [Full Text] [Related]

  • 34. [Physical training and low-dose heparin-calcium in patients suffering from chronic obliterating arteriopathy of the lower limbs with intermittent claudication].
    Cina G, Vernich M, Campisi C, Cascone C, Ofria F, Leopardi N, Maniscalco G, Moricca N, Ceccarelli V, Paolicelli D, Carbone D.
    Minerva Cardioangiol; 1996 Apr 02; 44(4):179-85. PubMed ID: 8767599
    [Abstract] [Full Text] [Related]

  • 35. [Conservative therapy of arterial occlusive diseases. Double-blind study on the effect of butalamine hydrochloride].
    Seboldt H.
    Fortschr Med; 1980 Feb 21; 98(7):257-60. PubMed ID: 6767648
    [Abstract] [Full Text] [Related]

  • 36. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
    Paoletti V, Mammarella A, Alessandrini A, Barlattani M.
    Clin Ter; 1984 Jul 15; 110(1):29-36. PubMed ID: 6237843
    [No Abstract] [Full Text] [Related]

  • 37. Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation.
    Mozzi E, Chiurazzi D, Spinola A, Annoni F, Germiniani R.
    J Int Med Res; 1985 Jul 15; 13(6):317-21. PubMed ID: 4076530
    [Abstract] [Full Text] [Related]

  • 38. [Experiences with the treatment of peripheral vascular diseases with Xavin].
    Brücknerová O.
    Vnitr Lek; 1973 Apr 15; 19(4):379-86. PubMed ID: 4699159
    [No Abstract] [Full Text] [Related]

  • 39. [Acute affect of buflomedil hydrochloride (bufedil) on transcutaneously measured oxygen pressures in patients with peripheral arterial occlusive disease].
    Lemke R, Klaus D.
    Vasa; 1984 Apr 15; 13(2):171-4. PubMed ID: 6741240
    [No Abstract] [Full Text] [Related]

  • 40. Suicide by buflomedil HCl: a case report.
    Neri C, Barbareschi M, Turrina S, De Leo D.
    J Clin Forensic Med; 2004 Feb 15; 11(1):15-6. PubMed ID: 15261008
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.